Cleared Traditional

K913243 - BENNETT X-RAY HORIZ RADIO FLOAT/HI-LO ELEV TABLE (FDA 510(k) Clearance)

Class I Radiology device.

K913243 · Bennett X-Ray Corp. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1991
Decision
59d
Days
Class 1
Risk

K913243 is an FDA 510(k) clearance for the BENNETT X-RAY HORIZ RADIO FLOAT/HI-LO ELEV TABLE. Classified as Phantom, Anthropomorphic, Radiographic (product code IXG), Class I - General Controls.

Submitted by Bennett X-Ray Corp. (Copiague, US). The FDA issued a Cleared decision on September 19, 1991 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1950 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bennett X-Ray Corp. devices

Submission Details

510(k) Number K913243 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 1991
Decision Date September 19, 1991
Days to Decision 59 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 107d · This submission: 59d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code IXG Phantom, Anthropomorphic, Radiographic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 892.1950
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.